StockWatch
·
HomeLiveReports
Filing
Q3

Amanta Healthcare Ltd

AMANTAFY2610 Feb 2026
Revenue+5.1%
Net Profit+283.3%
OPM20.62%

P&L

Quarterly Standalone

Revenue
+5.1%74.49
Expenditure
+4.3%68.86
Net Profit
+283.3%4.63
NPM 6.16%+262.4%EPS ₹1.35+285.7%

vs Q2 FY26

Amanta Healthcare Ltd Reports 51% YoY Profit Growth in 9MFY26, Despite Major Capacity Expansion

11 Feb 2026 · 11 Feb, 1:54 pm

Summary

Amanta Healthcare Ltd, a pharmaceutical company engaged in development, manufacturing, and marketing of sterile liquid products, reported a 51% YoY profit growth in 9MFY26. The company's revenue increased 3.97% YoY to INR 211 cr, and net profit grew 51.3% YoY to INR 9 cr. The company is executing a focused growth roadmap driven by wallet share expansion in complex therapies, scaling high-margin SteriPort and SVP capacities, and structural cost optimization through green energy initiatives.

Key Highlights

  1. 1

    Q3FY26 revenue stood at INR 75 cr, registering a 9.8% YoY growth

  2. 2

    9MFY26 revenue reached INR 211 cr, marking a 3.97% YoY increase

  3. 3

    Operating EBITDA for Q3FY26 came in at INR 15 cr with margins at 20.62%

  4. 4

    9MFY26 EBITDA increased 6.06% YoY to INR 45 cr, with margins improving by 42 bps YoY to 21.31%

  5. 5

    Net Profit for Q3FY26 rose to INR 5 cr, up 8.1% YoY

  6. 6

    9MFY26 PAT grew 51.3% YoY to INR 9 cr

  7. 7

    Q3FY26 PAT margin stood at 6.21%

  8. 8

    9MFY26 PAT margin expanded by 139 bps YoY to 4.43%

  9. 9

    Company is executing a focused growth roadmap driven by wallet share expansion in complex therapies, scaling high-margin SteriPort and SVP capacities, and structural cost optimization through green energy initiatives

Management Comments

B

Bhavesh Patel

Chairman & Managing Director, Amanta Healthcare Limited

We have reported a robust performance during the nine months of FY26, even as we undertook focused initiatives to support future growth. These initiatives are expected to start reflecting in our performance in the coming quarters. Our Revenue increased 3.97% YoY to 2210.7 crore, while EBITDA grew 6.06% YoY to 244.9 crore. Operational PAT rose 51.3% YoY to 29.3 crore, with Operating PAT margins expanding by 139 bps to 4.43%, underscoring the strength and resilience of our business model.

Informational and educational content only. Not investment advice.